Bone marrow-derived clonal mesenchymal stem cells as a source of cell therapy for promoting vocal fold wound healing

Young Mo Kim, Tac Ghee Yi, Jeong Seok Choi, Songyi Lee, Yun Ho Jang, Chul Ho Kim, Sun U. Song, Jae Yol Lim

Research output: Contribution to journalArticlepeer-review

26 Citations (Scopus)


Objectives: We investigated whether mouse bone marrow-derived clonal mesenchymal stem cells (BM-cMSCs) could promote vocal fold (VF) wound healing by using a xenograft animal model. Methods: Homogeneous BM-cMSCs isolated by a subfractionation culturing method from the bone marrow aspirates of green fluorescent protein transgenic mice were injected into the VFs of rabbits immediately after direct mechanical injury. Macroscopic, biomechanical (rheometric), histologic, immunohistochemical, and transcriptional evaluations were performed on the scarred VFs 1 to 3 months after injury. Engraftment of the implanted BM-cMSCs was determined by detection of green fluorescent protein cells in the recipient VF by confocal microscopy. Results: The BM-cMSC-treated VFs showed improved morphological properties and viscoelasticity as compared to control VFs injected with phosphate-buffered saline solution. Histologic and immunohistochemical evaluations showed less excessive collagen deposition and increased density of glycosaminoglycans in the BM-cMSC-treated VFs as compared to the control VFs at 3 months after injury (p = 0.003 and p = 0.037, respectively). BM-cMSC transplantation led to a significant attenuation of fibronectin (p = 0.036) and transforming growth factor β1 (p = 0.042) messenger RNA expression at 1 month after injury. Green fluorescent protein-expressing BM-cMSCs engrafted in recipient VFs were found at 1 month after implantation. Conclusions: BM-cMSCs appeared to survive in the injured xenogeneic VFs after transplantation for up to 1 month and favorably enhanced the wound healing of VFs after injury. We conclude that BM-cMSCs are a possible source of cell therapy for vocal fold regeneration.

Original languageEnglish
Pages (from-to)121-130
Number of pages10
JournalAnnals of Otology, Rhinology and Laryngology
Issue number2
Publication statusPublished - 2013 Feb

Bibliographical note

Funding Information:
From the Department of Otorhinolaryngology-Head and Neck Surgery (Y.-M. Kim, Yi, Choi, Lee, Jang, Lim), the Clinical Research Center (Y.-M. Kim, Yi, Choi, Lee, Jang, Song, Lim), and the Inha Research Institute for Medical Sciences (Yi, Song), Inha University School of Medicine, Incheon, and the Department of Otorhinolaryngology, Ajou University School of Medicine, Suwon (C.-H. Kim), Republic of Korea. This study was supported by the Basic Science Research Program of the National Research Foundation (NRF) funded by the Korean Ministry of Education, Science and Technology (grant 2011-0005812) and by an Inha University Research Grant. This study was also supported by the Bio & Medical Technology Development Program (2011-0019634) of the National Research Foundation of the Korean government (MEST). Authors Y.-M. Kim and Yi contributed equally to this study, as did authors Song and Lim.

All Science Journal Classification (ASJC) codes

  • Otorhinolaryngology


Dive into the research topics of 'Bone marrow-derived clonal mesenchymal stem cells as a source of cell therapy for promoting vocal fold wound healing'. Together they form a unique fingerprint.

Cite this